Generex Biotechnology to Initiate Phase III Clinical Trial of Generex Oral-lyn in 2007 Third Quarter
June 25, 2007 09:10 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 25, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced...
Generex Biotechnology to Make Presentations At the American Diabetes Association's 67th Scientific Sessions
June 22, 2007 13:23 ET
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 22, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) , the leader in drug delivery for metabolic diseases through the inner lining of the mouth,...